PureTech Health (PRTC) Operating Leases (2019 - 2025)

PureTech Health (PRTC) has 7 years of Operating Leases data on file, last reported at $11.1 million in Q4 2025.

• Operating Leases for Q4 2025 came in at $11.1 million, down 24.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.1 million (down 24.43% YoY), and the FY2025 annual result was $11.1 million, down 24.43% from the prior year.
• Operating Leases fell to $11.1 million in Q4 2025 per PRTC's latest filing, from $12.9 million in the prior quarter.
• Over five years, Operating Leases peaked at $33.0 million in Q4 2021 and troughed at $11.1 million in Q4 2025.
• A 5-year average of $19.8 million and a median of $16.4 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2021 and 2024: Operating Leases declined 6.67% in 2021, then sank 32.22% in 2024.
• A 5-year view of Operating Leases shows it stood at $33.0 million in 2021, then slipped by 11.71% to $29.1 million in 2022, then retreated by 25.69% to $21.6 million in 2023, then sank by 32.22% to $14.7 million in 2024, then slipped by 24.43% to $11.1 million in 2025.
• Business Quant data shows PRTC's Operating Leases at $11.1 million in Q4 2025, $12.9 million in Q2 2025, and $14.7 million in Q4 2024.